Лечение ковида во Франции

[Paki]

А знак вопроса к чему?

Наверное надо подождать официального заявления.

Может потому, что клинические испытания проводились с участием только невакцинированных людей.

« Merck is seeking an EUA for its pill for high-risk adults. In the clinical trial, molnupiravir was mostly given to people who were over 60 or those who were younger but had other conditions that put them at high risk of bad outcomes from COVID-19, such as diabetes, heart disease, or obesity. The FDA will also decide whether it should be given to vaccinated people—only unvaccinated individuals were included in the trial».